Date published: 2026-2-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

MYLK4 Activators

MYLK4 Activators represent a chemical class defined by their potential to upregulate or enhance the activity of Myosin Light Chain Kinase 4 (MYLK4), a serine/threonine-specific protein kinase. This diverse group of molecules is unified by their interaction with the MYLK4 enzyme, a member of the myosin light-chain kinase family, which plays a crucial role in phosphorylating the regulatory light chain of myosin II. The interaction dynamics of these activators with MYLK4 are multifaceted, involving a range of biochemical pathways and molecular mechanisms. For example, some activators might bind directly to the enzyme, altering its conformation and thus enhancing its kinase activity. Others could act indirectly, modulating the expression of MYLK4 at the transcriptional level or influencing post-translational modifications that govern the enzyme's activity or stability.The chemical structures within this class are varied, reflecting the complexity of the biological processes they potentially interact with. They encompass small organic molecules, natural products, and synthesized compounds. The diversity in their structure corresponds to the diversity in their modes of action. Some may mimic natural substrates or ligands of MYLK4, interacting with the enzyme's active site or allosteric sites to modulate its activity. Others might influence the cellular environment or signaling pathways that indirectly lead to increased MYLK4 activity. For instance, certain compounds might enhance MYLK4 expression by altering intracellular signaling cascades or modulating gene transcription factors. The molecular biology underlying these interactions is intricate, as MYLK4 itself is part of a complex network of cellular processes, including but not limited to the phosphorylation of myosin light chains, which plays a significant role in muscle contraction and cellular movement. Understanding the specific molecular interactions and the resultant biochemical consequences of MYLK4 activation by these compounds is crucial for comprehending their role in the context of cellular physiology.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin, known to increase cAMP levels, might enhance MYLK4 expression by activating cAMP-dependent pathways, leading to transcriptional changes.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA, as a PKC activator, could upregulate MYLK4 by activating protein kinase C (PKC) and influencing downstream signaling pathways.

Lithium

7439-93-2sc-252954
50 g
$214.00
(0)

Lithium, known for modulating GSK-3β activity, could potentially upregulate MYLK4 through Wnt signaling pathway modulation.

Sodium Butyrate

156-54-7sc-202341
sc-202341B
sc-202341A
sc-202341C
250 mg
5 g
25 g
500 g
$31.00
$47.00
$84.00
$222.00
19
(3)

Sodium butyrate, a histone deacetylase inhibitor, might promote MYLK4 expression by altering chromatin structure and enhancing gene transcription.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

As a DNA methyltransferase inhibitor, 5-Azacytidine could potentially induce MYLK4 expression by reducing DNA methylation and activating gene expression.

Trichostatin A

58880-19-6sc-3511
sc-3511A
sc-3511B
sc-3511C
sc-3511D
1 mg
5 mg
10 mg
25 mg
50 mg
$152.00
$479.00
$632.00
$1223.00
$2132.00
33
(3)

Trichostatin A, another histone deacetylase inhibitor, might enhance MYLK4 expression by affecting chromatin remodeling and gene activation.

Isoproterenol Hydrochloride

51-30-9sc-202188
sc-202188A
100 mg
500 mg
$28.00
$38.00
5
(0)

Isoproterenol, a beta-adrenergic agonist, could potentially upregulate MYLK4 through beta-adrenergic receptor signaling pathways.